Alzheimer's Disease Research Center (ADRC), University of Washington


The UW Alzheimer’s Disease Research Center (ADRC) is one of a nationwide network of 30 research resource centers funded by the National Institute on Aging. ADRCs are major sources of discovery into the nature of Alzheimer’s disease and related dementias and into the development of more effective approaches to prevention, diagnosis, care, and therapy. The UW ADRC contributes to the development of shared resources that support dementia-relevant research, and coordinates research efforts with other NIH-funded programs and investigators. UW ADRC resources are designed to facilitate and empower related research efforts at UW.

The UW ADRC is closely affiliated with the UW Memory and Brain Wellness Center clinic and links the Seattle community with information and opportunities to participate in studies of Alzheimer’s disease and related disorders (Lewy Body dementia, and frontotemporal degeneration, and vascular dementia). Our busy outreach team is influential in promoting strengths-based reframing of Alzheimer’s disease and dementia-friendly communities, and they organize and promote educational public talks and events and research seminars. We support outreach and culturally adapted Alzheimer’s disease programs for Indigenous communities and clinics. Join us!

Director: Dr. Thomas J. Grabowski, MD
Program Manager: Annika Noreen, PhD, PMP


October 21st: The Garvey Institute for Brain Health Solutions will host speaker Dr. Kristine Yaffe, MD, UCSF

October 08, 2019 — Dr. Kristine Yaffe, MD, Professor of Psychiatry, Neurology, and Epidemiology, UCSF, will present 'Population-Based Strategies for Improving Brain Health.' She will discuss the latest findings and public health implications of modifiable risk factors that could substantially impact brain health, including physical and cognitive activity, and sleep. Monday Oct 21, 2019. 8:00AM. UWMC Health Sciences, Room T739

Call for Pilot Project Applications for the Native Alzheimer’s Disease Resource Center for Minority Aging Research (NAD RCMAR).

October 07, 2019 — The NAD RCMAR program is an 18-month research training program in which investigators will complete both a pilot study and a grant proposal. The pilot studies are aimed to encourage junior investigators and those new to the field to pursue Alzheimer’s and related dementias and health disparities research. Letters of Intent are due by November 15, 2019.

New NIA funding aims to diversify and reinvigorate the Alzheimer’s disease drug development pipeline

October 02, 2019 — On October 1, the National Institute on Aging (NIA) announced that it will infuse $73 million into the Alzheimer's Centers for the Discovery of New Medicines over the next five years, to transform big data into open-access targets and drugs for testing in clinical trials. Sage Bionetworks in Seattle, a member of one of these new centers and UW ADRC collaborator, will help leverage the data and results from the Accelerating Medicines Partnership-Alzheimer's Disease (AMP-AD) program and develop a series of new therapeutic hypotheses centered around a prioritized set of novel targets.

Upcoming Research Events